Healthcare provider profile · identity verified

Raja Mohan Chakrapani, MD

Allopathic & Osteopathic Physicians|Internal Medicine · TURTLE CREEK, PA · NPI 1366424541

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Raja Mohan Chakrapani, MD received $159.96 in general payments during 2025 across 3 reported records.

Lilly USA, LLC accounted for 91.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 176 claims for Trelegy Ellipta by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 262 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 64 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$159.96

3 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$146.17	91.4%	2	2025
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$13.79	8.6%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$114.96	2
Education	$45.00	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$101.17	1	2025
Source payment records 2025-04-09 · Lilly USA, LLC · $101.17 · Open Payments source
TRELEGY ELLIPTA Normalized: trelegy ellipta	Drug	GlaxoSmithKline, LLC.	$13.79	1	2025
Source payment records 2025-09-02 · GlaxoSmithKline, LLC. · $13.79 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
TRELEGY ELLIPTA trelegy ellipta	2025	Trelegy Ellipta	2024	176	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	TRELEGY ELLIPTA open payments reported associated product	CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369	Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row	176	36
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	262	40
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	21	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	64	20

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1755	319
Amlodipine Besylate	Amlodipine Besylate	1441	250
Lisinopril	Lisinopril	1103	190
Pantoprazole Sodium	Pantoprazole Sodium	1075	201
Levothyroxine Sodium	Levothyroxine Sodium	918	148
Gabapentin	Gabapentin	832	132
Furosemide	Furosemide	734	141
Eliquis	Apixaban	727	109
Metformin Hcl	Metformin Hcl	680	120
Metoprolol Succinate	Metoprolol Succinate	611	140
Trazodone Hcl	Trazodone Hcl	591	93
Tamsulosin Hcl	Tamsulosin Hcl	587	104
Sertraline Hcl	Sertraline Hcl	555	84
Metoprolol Tartrate	Metoprolol Tartrate	524	100
Omeprazole	Omeprazole	510	100
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	444	69
Carvedilol	Carvedilol	438	80
Risperidone	Risperidone	431	51
Olanzapine	Olanzapine	429	48
Rosuvastatin Calcium	Rosuvastatin Calcium	401	86
Potassium Chloride	Potassium Chloride	397	85
Famotidine	Famotidine	380	63
Quetiapine Fumarate	Quetiapine Fumarate	366	54
Simvastatin	Simvastatin	361	61
Clopidogrel	Clopidogrel Bisulfate	349	73
Albuterol Sulfate Hfa	Albuterol Sulfate	343	93
Losartan Potassium	Losartan Potassium	342	84
Lorazepam	Lorazepam	329	68
Ibuprofen	Ibuprofen	311	64
Aripiprazole	Aripiprazole	297	36
Alprazolam	Alprazolam	285	47
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	284	65
Levetiracetam	Levetiracetam	279	36
Mirtazapine	Mirtazapine	274	53
Hydrochlorothiazide	Hydrochlorothiazide	269	53
Jardiance	Empagliflozin	262	40
Donepezil Hcl	Donepezil Hcl	245	28
Vitamin D2	Ergocalciferol (Vitamin D2)	228	35
Breo Ellipta	Fluticasone/Vilanterol	223	40
Fluoxetine Hcl	Fluoxetine Hcl	217	30
Prednisone	Prednisone	217	64
Citalopram Hbr	Citalopram Hydrobromide	212	28
Oxycodone Hcl	Oxycodone Hcl	211	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	211	29
Meloxicam	Meloxicam	209	54
Duloxetine Hcl	Duloxetine Hcl	207	44
Escitalopram Oxalate	Escitalopram Oxalate	205	40
Buspirone Hcl	Buspirone Hcl	203	31
Montelukast Sodium	Montelukast Sodium	192	32
Zolpidem Tartrate	Zolpidem Tartrate	189	25
Haloperidol	Haloperidol	177	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	176	36
Divalproex Sodium	Divalproex Sodium	174	20
Finasteride	Finasteride	173	29
Pravastatin Sodium	Pravastatin Sodium	172	36
Benztropine Mesylate	Benztropine Mesylate	169	19
Metformin Hcl Er	Metformin Hcl	157	30
Fenofibrate	Fenofibrate Nanocrystallized	156	27
Ondansetron Hcl	Ondansetron Hcl	147	47
Fluticasone Propionate	Fluticasone Propionate	142	51
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	141	29
Perphenazine	Perphenazine	140	11
Lamotrigine	Lamotrigine	136	14
Bupropion Xl	Bupropion Hcl	133	18
Hydralazine Hcl	Hydralazine Hcl	131	27
Xarelto	Rivaroxaban	125	23
Spironolactone	Spironolactone	121	31
Humalog Kwikpen U-100	Insulin Lispro	120	29
Latanoprost	Latanoprost	116	20
Warfarin Sodium	Warfarin Sodium	116	19
Doxycycline Hyclate	Doxycycline Hyclate	113	65
Ropinirole Hcl	Ropinirole Hcl	109	23
Amiodarone Hcl	Amiodarone Hcl	106	20
Baclofen	Baclofen	104	17
Celecoxib	Celecoxib	104	15
Azithromycin	Azithromycin	101	87
Clonazepam	Clonazepam	101	23
Entresto	Sacubitril/Valsartan	100	18
Venlafaxine Hcl Er	Venlafaxine Hcl	99	12
Invega Sustenna	Paliperidone Palmitate	98	15
Bumetanide	Bumetanide	96	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	96	18
Methocarbamol	Methocarbamol	89	26
Diclofenac Sodium	Diclofenac Sodium	88	23
Divalproex Sodium Er	Divalproex Sodium	87	suppressed
Atenolol	Atenolol	86	21
Nystatin	Nystatin	86	46
Allopurinol	Allopurinol	85	29
Carbidopa-Levodopa	Carbidopa/Levodopa	85	11
Januvia	Sitagliptin Phosphate	85	12
Topiramate	Topiramate	85	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	84	18
Meclizine Hcl	Meclizine Hcl	84	25
Tramadol Hcl	Tramadol Hcl	83	22
Sucralfate	Sucralfate	82	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	80	19
Digoxin	Digoxin	80	suppressed
Glipizide	Glipizide	80	17
Ketoconazole	Ketoconazole	80	19
Paroxetine Hcl	Paroxetine Hcl	80	15
Alendronate Sodium	Alendronate Sodium	79	14
Hydroxyzine Pamoate	Hydroxyzine Pamoate	78	26
Ozempic	Semaglutide	77	21
Ventolin Hfa	Albuterol Sulfate	77	16
Novolog Flexpen	Insulin Aspart	76	19
Amoxicillin	Amoxicillin	68	51
Insulin Aspart Flexpen	Insulin Aspart	68	19
Midodrine Hcl	Midodrine Hcl	68	11
Pregabalin	Pregabalin	67	16
Tradjenta	Linagliptin	67	suppressed
Ibu	Ibuprofen	66	23
Klor-Con M10	Potassium Chloride	66	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	64	suppressed
Trulicity	Dulaglutide	64	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	63	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	62	42
Paliperidone Er	Paliperidone	61	suppressed
Glimepiride	Glimepiride	58	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	57	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	48
Lithium Carbonate	Lithium Carbonate	57	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	56	suppressed
Cefuroxime	Cefuroxime Axetil	55	45
Insulin Lispro Kwikpen U-100	Insulin Lispro	55	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	13
Repaglinide	Repaglinide	55	suppressed
Valsartan	Valsartan	55	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	54	suppressed
Gemfibrozil	Gemfibrozil	54	suppressed
Nifedipine Er	Nifedipine	54	16
Ondansetron Odt	Ondansetron	54	22
Incruse Ellipta	Umeclidinium Bromide	52	suppressed
Bupropion Hcl Sr	Bupropion Hcl	51	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	51	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	50	18
Enalapril Maleate	Enalapril Maleate	49	suppressed
Glipizide Er	Glipizide	49	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	49	suppressed
Fluconazole	Fluconazole	48	23
Lovastatin	Lovastatin	47	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	47	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	46	suppressed
Ezetimibe	Ezetimibe	46	11
Clonidine Hcl	Clonidine Hcl	45	15
Amantadine	Amantadine Hcl	43	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	43	suppressed
Cephalexin	Cephalexin	42	34
Loperamide	Loperamide Hcl	42	27
Triamcinolone Acetonide	Triamcinolone Acetonide	42	25
Calcium Acetate	Calcium Acetate	41	suppressed
Timolol Maleate	Timolol Maleate	41	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	40	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Primidone	Primidone	40	suppressed
Farxiga	Dapagliflozin Propanediol	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	37	18
Memantine Hcl	Memantine Hcl	37	suppressed
Lithium Carbonate Er	Lithium Carbonate	36	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	35	suppressed
Naproxen	Naproxen	35	13
Paxlovid	Nirmatrelvir/Ritonavir	35	34
Acetaminophen-Codeine	Acetaminophen With Codeine	34	suppressed
Doxepin Hcl	Doxepin Hcl	34	suppressed
Nyamyc	Nystatin	34	15
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	34	suppressed
Lactulose	Lactulose	33	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	33	suppressed
Anastrozole	Anastrozole	32	suppressed
Clotrimazole	Clotrimazole	32	12
Pen Needles	Pen Needle, Diabetic	32	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Brilinta	Ticagrelor	29	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Ingrezza	Valbenazine Tosylate	29	suppressed
Valacyclovir	Valacyclovir Hcl	28	12
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	27	17
Naltrexone Hcl	Naltrexone Hcl	27	suppressed
Oxcarbazepine	Oxcarbazepine	27	suppressed
Latuda	Lurasidone Hcl	26	suppressed
Olanzapine Odt	Olanzapine	26	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	26	suppressed
Vraylar	Cariprazine Hcl	26	suppressed
Xtampza Er	Oxycodone Myristate	26	suppressed
Hydrocortisone	Hydrocortisone	25	suppressed
Nitroglycerin	Nitroglycerin	25	14
Suboxone	Buprenorphine Hcl/Naloxone Hcl	25	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Folic Acid	Folic Acid	24	suppressed
Methimazole	Methimazole	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	14
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	23	suppressed
Flecainide Acetate	Flecainide Acetate	23	suppressed
Oxycontin	Oxycodone Hcl	23	suppressed
Single Use Swab	Alcohol Antiseptic Pads	23	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Diazepam	Diazepam	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Etodolac	Etodolac	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	20	suppressed
Temazepam	Temazepam	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Lyumjev Kwikpen U-100	Insulin Lispro-Aabc	19	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	19	11
Amiloride Hcl	Amiloride Hcl	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Carbamazepine Er	Carbamazepine	17	suppressed
Clozapine	Clozapine	17	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	17	suppressed
Ssd	Silver Sulfadiazine	17	suppressed
Admelog Solostar	Insulin Lispro	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Sotalol	Sotalol Hcl	15	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Haloperidol Lactate	Haloperidol Lactate	14	suppressed
Lurasidone Hcl	Lurasidone Hcl	14	suppressed
Metolazone	Metolazone	14	suppressed
Combigan	Brimonidine Tartrate/Timolol	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Heparin Sodium	Heparin Sodium,porcine	13	suppressed
Klor-Con 10	Potassium Chloride	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Abilify Maintena	Aripiprazole	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Lybalvi	Olanzapine/Samidorphan Malate	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Acetazolamide	Acetazolamide	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Meropenem	Meropenem	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$159.96 · 3 records	Lilly USA, LLC	TRELEGY ELLIPTA, ZEPBOUND	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error